EUVIMEDEUVIMED entdecken
Crossref

Dual‐Mode Centrifugal Microfluidics for High‐Throughput Immunoassays and Rapid Nucleic Acid Purification

Hiep Van Nguyen, Huynh Quoc Nguyen, Vu Minh Phan, So Jeong Park, Tae Seok Seo iD

Small · 2026

DOI: 10.1002/smll.202511107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Hiep Van Nguyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering (BK21 FOUR Integrated Engineering Program), College of Engineering, Kyung Hee University, Yongin, Republic of Kore…. Hauptthemen laut MEDLINE: Microfluidics, Nucleic Acids, High-Throughput Screening Assays. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A universal, dual‐mode microfluidic platform is presented for high‐throughput (HTP) biochemical analysis, capable of performing either enzyme‐linked immunosorbent assays (ELISA) as well as rapid nucleic acid (NA) purification within a single lab‐on‐a‐disc. Assay‐specific functionality is achieved by simply coating antibodies for immunoassays or inserting glass fiber membranes for NA extraction, eliminating the need for multiple chip designs. A self‐pressure‐balanced zigzag distributor generates a capillary pressure gradient that enables fast and uniform reagent distribution across all 30 units with a single injection, preventing overflow and residual blockage under high‐speed injection or repeated centrifugation steps. In addition, integrated siphon valves and bifurcation chambers precisely control fluid movement for incubation, washing, detection, and elution steps. In ELISA mode, the platform automates the full workflow and delivers results for 30 tests in under 1 h. In NA mode, RNA is extracted and eluted for downstream qPCR analysis. Using SARS‐CoV‐2 as a model, the platform demonstrates the ability to detect nucleocapsid protein via ELISA and confirm results through qPCR, enabling orthogonal validation and enhanced diagnostic reliability. This reconfigurable, dual‐mode system offers a unified solution for protein and nucleic acid testing, ideally suited for scalable deployment in clinical diagnostics, outbreak response, and translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrofluidicsNucleic AcidsHigh-Throughput Screening AssaysSARS-CoV-2Enzyme-Linked Immunosorbent AssayHumansCOVID-19ImmunoassayCentrifugationLab-On-A-Chip DevicesRNA, Viral

Stichwörter der Autor:innen

ELISAcentrifugal microfluidichigh‐throughputimmunoassaysnucleic acidpoint‐of‐care testing

Substanzen

Nucleic AcidsRNA, Viral

Autor:innen und Institutionen

  • Department of Chemical Engineering (BK21 FOUR Integrated Engineering Program), College of Engineering, Kyung Hee University, Yongin, Republic of Korea.

ORCID-Profile: Tae Seok Seo

Förderung

  • National Research Foundation of Korea
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Van Nguyen, H., Nguyen, H. Q., Phan, V. M., Park, S. J., & Seo, T. S. (2026). Dual‐Mode Centrifugal Microfluidics for High‐Throughput Immunoassays and Rapid Nucleic Acid Purification. Small. https://doi.org/10.1002/smll.202511107

Vancouver

Van Nguyen H, Nguyen HQ, Phan VM, Park SJ, Seo TS. Dual‐Mode Centrifugal Microfluidics for High‐Throughput Immunoassays and Rapid Nucleic Acid Purification. Small. 2026. doi:10.1002/smll.202511107

BibTeX
@article{VanNguyen2026,
  author = {Van Nguyen, Hiep and Nguyen, Huynh Quoc and Phan, Vu Minh and Park, So Jeong and Seo, Tae Seok},
  title = {Dual‐Mode Centrifugal Microfluidics for High‐Throughput Immunoassays and Rapid Nucleic Acid Purification},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.202511107}
}
Kostenlos starten →